Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
176 hedge funds and large institutions have $807M invested in Meridian Bioscience Inc in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 65 increasing their positions, 50 reducing their positions, and 17 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 50
22% more capital invested
Capital invested by funds: $659M → $807M (+$148M)
20% more call options, than puts
Call options by funds: $3.53M | Put options by funds: $2.93M
18% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 17
1% more funds holding
Funds holding: 175 → 176 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$16.4M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$12.6M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.76M |
| 4 |
Renaissance Technologies
New York
|
+$3.51M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$17.3M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$3.73M |
| 3 |
Millennium Management
New York
|
-$3.54M |
| 4 |
CPCM
Clifton Park Capital Management
Wilmington,
Delaware
|
-$2.97M |
| 5 |
Bank of New York Mellon
New York
|
-$2.43M |
VIVO Hedge Fund Activity: Q4 2015 in Review
176 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q4 2015, worth a combined $807M — up 22% from $659M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new VIVO positions and 17 closed out — a net gain of 3 holders — while 65 added to existing stakes and 50 trimmed.
The largest buyer was Boston Trust Walden, opening a new position worth an estimated $16.4M. The largest seller was Neuberger Berman Group, cutting an estimated $17.3M.
- 176 institutional investors held Meridian Bioscience Inc (VIVO) as of Q4 2015, up from 175 in Q3 2015.
- Funds reported $807M of Meridian Bioscience Inc stock for Q4 2015, up 22% quarter-over-quarter.
- 20 funds opened new Meridian Bioscience Inc positions in Q4 2015 and 17 closed out, a net change of +3 holders.
- The largest Meridian Bioscience Inc buyer in Q4 2015 was Boston Trust Walden, an estimated $16.4M added.
- The largest Meridian Bioscience Inc seller in Q4 2015 was Neuberger Berman Group, an estimated $17.3M sold.
Based on aggregated 13F filings for Q4 2015.